- Home
- GSK vs AJG Comparison
GSK vs AJG Comparison
Compare GSK & AJG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- AJG
- Stock Information
- Founded
- GSK 1715
- AJG 1927
- Country
- GSK United Kingdom
- AJG United States
- Employees
- GSK N/A
- AJG N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- AJG Specialty Insurers
- Sector
- GSK Health Care
- AJG Finance
- Exchange
- GSK Nasdaq
- AJG Nasdaq
- Market Cap
- GSK 74.6B
- AJG 70.6B
- IPO Year
- GSK N/A
- AJG N/A
- Fundamental
- Price
- GSK $36.64
- AJG $325.48
- Analyst Decision
- GSK Hold
- AJG Hold
- Analyst Count
- GSK 4
- AJG 13
- Target Price
- GSK $47.00
- AJG $303.38
- AVG Volume (30 Days)
- GSK 5.2M
- AJG 1.5M
- Earning Date
- GSK 02-05-2025
- AJG 01-30-2025
- Dividend Yield
- GSK 4.21%
- AJG 0.80%
- EPS Growth
- GSK N/A
- AJG 47.06
- EPS
- GSK 0.78
- AJG 6.50
- Revenue
- GSK $39,280,393,592.00
- AJG $10,927,400,000.00
- Revenue This Year
- GSK $6.43
- AJG $35.38
- Revenue Next Year
- GSK $5.34
- AJG $12.03
- P/E Ratio
- GSK $23.15
- AJG $50.07
- Revenue Growth
- GSK 3.46
- AJG 14.31
- 52 Week Low
- GSK $31.72
- AJG $230.08
- 52 Week High
- GSK $45.93
- AJG $329.60
- Technical
- Relative Strength Index (RSI)
- GSK 58.60
- AJG 66.86
- Support Level
- GSK $36.35
- AJG $322.67
- Resistance Level
- GSK $37.22
- AJG $327.99
- Average True Range (ATR)
- GSK 0.62
- AJG 5.36
- MACD
- GSK 0.04
- AJG 0.35
- Stochastic Oscillator
- GSK 65.58
- AJG 86.35
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About AJG Arthur J. Gallagher & Co.
Arthur J. Gallagher & Co provides insurance brokerage and consulting services to middle-market entities around the world. The majority of the company's revenue comes from its brokerage segment, where it negotiates and places its customers with insurance companies that provide, among other types, property/casualty and health insurance. The company's primary source of revenue in the brokerage segment is commissioning from the insurance companies. The company also generates significant revenue in its corporate segment, which includes clean energy investment and other investment income. The company generates most of its revenue in the United States, with the remaining revenue coming primarily from Australia, Bermuda, Canada, the Caribbean, New Zealand, and the United Kingdom.